chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The mornign after getting the vaccination she woke up and said she didn't feel well then passed out.
Severe lymph node swelling and discomfort. Bruising and pain at injection site. Severe lethargy and disorientation. Loss of dexterity in left arm, some tingling.  All of this started within 12 hours of administration.
headache; achiness; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced headache and pain. On an unknown date, the outcome of the headache and pain were unknown.   It was unknown if the reporter considered the headache and pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but was selected as an adult as per vaccine indication. The patient had received shingrix and experienced headache and achiness. Patient had questioned to take Tylenol after the 2nd vaccine. No other information was reported.
Pt reported to have pain in the arm that radiated to the neck and caused numbness and pain in the arm that extended to the fingers.  These adverse reactions started several days after the "usual" side effects resolved, they started 7/13/2022 at  approximately 11 A.M.
Systemic: Vomiting-Medium, Additional Details: Pt called to tell us he vomiting the morning after he received the vaccine. RPH on Duty counsled him to seek medical treatment as he said he did not feel well. RPH followed up with the pt later in the day and he had gone to urgent care where they said this is a common reaction with Moderna and instructed him to take Claritin.
painful arms (site of inject), headache, neck hurting, pale, sleeping excessively;
Stiff neck; Little headed a couple of times; Tired; Major headache; Fever; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 11Apr2021 at 14:30 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced tired, major headache, stiff neck, fever, chills, body aches and little headed a couple of times. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The clinical outcome of the events tired, major headache, stiff neck, fever, chills, body aches and little headed a couple of times were resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Mild rash (fewer than 50 tiny blisters) on front/back of torso, plus one in the crook of left elbow.  They're mildly itchy.  Also had fatigue, headaches and body aches which started about the same time (morning of April 29, 2029)  The head/body aches and tiredness lasted about 12 hours.
Immediately hit with dizzy spells. Was told to drink water and sit for 15 minutes. Left after 20 minutes and continued to feel tired and dizzy. Throughout the evening and night skin began to itch, my neck tightened up, my skin became extremely sensitive to touch, chills and shakes started to happen. I took an over the counter medicine lime Tylenol yet nothing has been helping. I current still have everything I described and a massive headache.  I am unable to move my left arm without extreme pain and the pain has been spreading down the arm.
THROAT IRRITATION 71 yo male with hx onychomycosis due to dermatophyte reported throat irritation during the post observation period. Patient reported 3/10 "tickle" in the throat when he swallowed following first dose of Covid-19 vaccine. BP 156/95, 64, 97.5, RR 14, 97% O2. Denied chest pain and shortness of breath. Patient drank water without difficulty during thirty minute monitoring. Patient was unchanged after one hour fifteen minutes. Re-take of vital signs BP 160/103, HR 56, 97% O2. Pt was taken to the ED where they renewed his EpiPen. He stated that he had used it in the past. Pt was discharged the same day. The patient denied any prior severe reaction to this vaccine or its components or a severe allergic reaction such as anaphylaxis to any vaccine or to any injectable therapy. Vaccine administered without complications.
Positive for Covid after 1st vaccine injection; Lost my sense of smell; A spontaneous report was received from a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced lost sense of smell and positive for COVID-19 after first vaccine injection.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 25 Dec 2020, the patient stated that she had a few symptoms of Covid-19 and got tested, it was negative.   On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 31 Dec 2020, the day after administration, the patient experienced lost sense of smell. On the same day, she took a Covid-19 test, which was positive. No treatment was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome for events, lost sense of smell and positive for COVID-19 after 1st vaccine injection, were unknown.; Reporter's Comments: very limited information regarding this event has been provided. However, the events of (anosmia, Covid-19) is Unlikely related to mRNA-1273 and Further information has been requested
Pain and swelling at site, notified clinic on 05/23/06 and they recommended warm compresses. Began draining on 05/29/06, went to local emergency department on 05/30/06 and was given Bactrim DS. On 06/01/2006, went to another emergency department with drainage, pain and odor at site. I&D was performed of the abscess, packing placed, given Vicodin and Keflex.
2hr p/v pt fever spiked to 105 & began shaking uncontrollably;had difficulty breathing & called 911;
pt recvd vax 7JUN95 & 24JUN95 pt devel generalized red maculopapular rash;rash resolved spontaneously & pt recovered;No further details were provided;
Pt called health system call center c/o vaccine side effects. Verified pt with 2 identifiers. Proceed the screening questions of covid vaccine side effects. Noted no emergency s/sx. Pt stated pt got covid vaccine J&J 5/13/2021 at VSC and then Headache, body aches, joint pain, sore throat, chills, cough, sore throat, fever started from Monday 5/17/2021. Pt is taking tylenol and ibuprofen for the symptoms.  Pt scheduled urgent care provider 5/21/2021 for consultations. Pt made aware. Pt is educated covid vaccine side effects. Pt agreed and verbalized understanding.
itching at injection site; redness "pinky" at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itching at injection site) and INJECTION SITE ERYTHEMA (redness "pinky" at injection site) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced INJECTION SITE PRURITUS (itching at injection site) and INJECTION SITE ERYTHEMA (redness "pinky" at injection site). At the time of the report, INJECTION SITE PRURITUS (itching at injection site) and INJECTION SITE ERYTHEMA (redness "pinky" at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported No treatment medication was reported
Patient received the Shingrix dose 1 shot on 7/17/19.  He got a reaction a week later.  He had welts on his right side of this face.  He came back to the pharmacy on 7/31/19 to tell the pharmacist on duty.
I started losing facial hair, and now I am losing hair on my head.  I have Alopecia Areata, which is an  autoimmune disorder.  My dermatologist said it was likely caused by the vaccine.
High heart rate. 95 bpm at rest. (55-60 typical). Heart rate spike to 120-130 bpm with small walk. Heavy breathing. Light headedness on standing or urination.   Muscle aches and chills.
HYPOTENSION 3/26/2023 VENTRICULAR TACHYCARDIA, UNSPECIFIED TYPE
Pt contacted clinic on 3/29/01 to report progressive arthralgia that began "soon after" the vaccination. He noted swelling and pain, first in his left knee, then his left ankle, then in his right leg and then his arms. He was unsure about fevers. His symptoms seem worse each day and are unrelieved by NSAIDS. He was encouraged to see a PCP soon for further evaluation and treatment.  Follow up:  Patient did not state the exact date/time.  He reports his symptoms began "soon" after the vaccination given.
9 days after MMR administered for a rubella-susceptible, pt experienced increased joint pain to entire body. (L) knee & (L) wrist more painful with swelling. Denies fever or flu like symptom. Instructed to call PCP ASAP.
First experienced chest pressure and insomnia a few days after.  Then, GI flare up.  I was so sick I couldn't keep fluids down and ended up in the ER.  I started to feel better week 3, then had to get; First experienced chest pressure and insomnia a few days after.  Then, GI flare up.  I was so sick I couldn't keep fluids down and ended up in the ER.  I started to feel better week 3, then had to get; First experienced chest pressure and insomnia a few days after.  Then, GI flare up.  I was so sick I couldn't keep fluids down and ended up in the ER.  I started to feel better week 3, then had to get; First experienced chest pressure and insomnia a few days after.  Then, GI flare up.  I was so sick I couldn't keep fluids down and ended up in the ER.  I started to feel better week 3, then had to get; This is a spontaneous report from a contactable consumer (patient herself). A 35-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in right arm on 15Apr2021 10:30 as 1st dose, single dose for COVID-19 immunization. Patient was 35-years-old and was not pregnant at the time of vaccination. Patient medical history and concomitant medications were not reported. Patient was allergic to cephalexin, mucinex, nasonex. Facility where the most recent COVID-19 vaccine was administered was reported as Hospital. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination. Patient has been tested for COVID-19, since the vaccination. On 28Apr2021, patient first experienced chest pressure and insomnia a few days after vaccination. Then, GI flare up. She was so sick she could not keep fluids down and ended up in the ER. She started to feel better week 3, then had to get her second dose. The adverse events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. Patient received all sorts of stomach medications for the adverse events. Device Date was reported as 05Jun2021. The lab tests and procedures included nasal swab test on 06May2021 with result as negative. The outcome of the event was not recovered.   Information about lot batch number has been requested.
Itching around eyes; This is a spontaneous report from a non-contactable consumer (patient). A 49-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 23Feb2021 at 05:00 PM as DOSE 1, SINGLE (at the age of 48-years-old) for COVID-19 immunisation. The patient's medical history included Allergies: Sulfur containing antibiotics from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in 2021, the patient experienced itching around eyes. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Doctor prescribed Benadryl and cortisone cream. Neither the patient nor the doctor connected the event to the shot. The patient also received treatment for the adverse event, dosed herself with antihistamine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient received dose 2 of bnt162b2 (lot number: En6208) on 16Mar2021 at 12:00 PM at left arm for COVID-19 immunisation. The patient was recovering from the event.  No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
Pt seen for f/u of increased pain/swelling. Temp 99.2 degrees & swelling of upper (L) arm approximately equal to 2 3/4 in (L) x 2 in (W) with c/o tenderness to touch. C/o pain from (L) mid axilla to lower axilla.
Severe breathing difficulty, dizziness, heart palpitations. Went to emergency room at hospital.
Hard "knot" at site of shot underarm, with redness radiating to elbow at left arm. Instructed patient to take anti-inflammatory and BENADRYL, called today, 12/20/12, swelling & redness was almost.
(pt visited the clinic on 04/22/2021) Pt received J&J injection on left arm in the morning @ Store pharmacy 04/10/2021. Pt got chill, fever, body aches on the first day. However, 3 days ago, pt started to notice RT knee pain. Pt never had a knee pain like this before. Pt cannot pick up leg and it really hurts around the knee. Pt does not remember any trauma or injury to RT knee recently or from the past. Pt has been taking tylenol but not so helpful.  Naproxen 500mg BID rx'ed. Will f/u in 2wks.
Patient was admitted to Medical Center on 06-09-2023 from Hospital due to unresponsiveness and confusion. Was d/c'd on 06-19-2023 and admitted to hospice on 06-19-2023 The patient expired on 06-20-23 at 8:23pm.? Patient was Covid positive on 06-14-2023
Day 1: 9:00 am vaccine, significant burning sensation during injection, pain reduced gradually over :15, soreness when moving arm for 36 hours, no treatment; 11:00 am fatigue; noon-1:00 pm nap; 2:00 pm chills, fever (up to 101.7 F), body aches, extreme fatigue, treated with heating pads and sleep Day 2: 1:00 am additional symptom of a headache (not a migraine), treated with cold packs; 6:00 am chills, fever and body aches were gone, fatigue was not as severe, headache was worse; 3:00 pm headache was gone, fatigue minor Day 3: side effects gone, back to normal
12/7/2021 insomnia, hyper, sore arm, @5:30am...tachycardia 131, sweating, weak, tunnel vision, sugar 421, unstable, dizziness. Called 911 while waiting I took metoprolol 59mg, Vallarta 320,  Prednisone 20mg, Levemir 60 units. Stabilized by the time paramedics came. No hospitalization. 12/25/2021 had CVA. Hospital admission from 12/26 - 12/28.
BLOOD CLOT IN LEFT LEG; This spontaneous report received from a patient concerned a 48 year old, White and Hispanic or Latino female. The patient's height, weight and medical history were not reported. The patient had no blood clots in the past or no recent trauma and surgery. The patient was not on any medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072 and expiry: UNKNOWN) dose was not reported, 1 total, administered to the left arm, on 06-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAY-2021, the patient came into the hospital with swelling in left leg, a lot of heat and a lot of pain. In emergency room (ER) they did scans and tests and it was found that the patient had a blood clot in left leg. The patient has to stay in the hospital for 24 hours until the blood clot was resolved.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clot in left leg. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0;20210516127- covid-19 vaccine ad26.cov2.s-Blood Clot in left leg. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's neighbor. The age at vaccination was not reported. The patient got the Shingles shot and immediately got the shingles. The follow up would not be possible as no contact details were available.
Case number PHEH2012US010030 is an initial spontaneous report received from a medical assistant on 20 Apr 2012 with a follow up information received on 02 Jul 2012: This case refers to 11-months-old male patient. He was inadvertently vaccinated with MENVEO (batch number: X10057, expiry date: Feb 2013) at dose of 0.5 ml, intramuscularly on 20 Apr 2012. It was reported that MENVEO was given in error in place of MMR (batch number: not reported) vaccine. He was hospitalized on an unspecified date. No adverse event was reported following this administration error. No further information was available. Follow up information received on 02 Jul 2012: Patient demographics (height and weight) updated, MMR coded as suspect product, wrong vaccine administered coded as event, seriousness criterion was updated.
no adverse effects; a 4 year old patient was administered an expired dose of PROQUAD; This spontaneous report was received from a Licensed Practical concerning a 4 years old child patient of unknown race and gender. The patient's pertinent medical history, concurrent conditions, drug allergies or reactions, historical and concomitant drugs were not reported.  On 11-JUN-2019, the patient was vaccinated with an expired dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) recombinant human albumin (rHA) lot number N035173 with expiration date on 09-JUN-2019 (dose, frequency and route of administration were not reported) for prophylaxis. No adverse effects were reported.  The outcome of expired product administered was unknown.
allergic reaction on left arm increasing in size daily. Red, itchy, swollen, feverish, slightly painful. The redness is beginning to cover the entire arm.  Benadryl and Ibuprofen are not relieving the symptoms.  Symptoms occured on day 2 and are continuing adversely.to day 6 with no relief
Tongue throat tingly; Tongue throat tingly; hives; purple tongue in the back on sides; This is a spontaneous report from a contactable other HCP (patient). A 50-year-old female patient received first dose (BNT162B2, lot number EH9899) , intramuscular at Arm Left on 23Dec2020 12:00 at the 50 years old at single dose for COVID-19 immunization.  Medical history included Angio edema. The patient was not allergic to medications, food, or other products. Concomitant medication included pantoprazole(strength 40 mg), simvastatin (strength 20 mg), colecalciferol (D3, strength 5000iU), ascorbic acid, betacarotene, copper, tocofersolan, zinc (OCUVITE), ascorbic acid, calcium, minerals nos, retinol, tocopheryl acetate, vitamin b nos, vitamins nos, zinc (CENTRUM SILVER) , boron, calcium, cimicifuga racemosa extract, folic acid, glycine max extract, magnolia officinalis, nicotinic acid, pyridoxine hydrochloride, riboflavin, selenium, thiamine, tocopherol, vitamin b12 nos (ESTROVEN).  The patient experienced Tongue throat tingly, hives, purple tongue in the back on sides on 23Dec2020 18:00. The patient received Benadryl as the treatment for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered.
Severe arm pain, requiring ice and TYLENOL. I was also shivering uncontrollably.
Patient fainted shortly after receiving the vaccine. He was instructed to go have a seat in our observation area and wait for 15 minutes and I believe he fainted before he even sat down.  As I approached him he was already conscious again and i had him stay put just to make sure he was ok before getting back into the chair.  He was given water and he was closely monitored until his 15 minutes was up. A family member came to take him home just to be safe. While he was waiting he said it wasn't a seizure and he probably fainted because of his fear of needles. He mentioned it has happened multiple times before whenever he gets tattoos. None of this was indicated when he filled out his vaccine consent form.
Pericarditis leading to pericardial effusion; Pericarditis leading to pericardial effusion; This is a spontaneous report from a contactable other hcp (Patient). A 57-year-old male patient received bnt162b2, dose 1 via an unspecified route of administration, administered in arm right on 01Mar2021 (Lot Number: EN6201) as single dose for COVID-19 immunisation. Age at vaccination was 57-year-old. Medical history included chronic pancreatitis, gastritis from an unknown date. No Known allergies. No covid prior vaccination. Concomitant medications in two weeks included amlodipine; losartan; trazodone; ascorbic acid, betacarotene, biotin, calcium, chromium, copper, folic acid, iodine, iron, magnesium, manganese, molybdenum, nicotinic acid, pantothenic acid, phosphorus, pyridoxine hydrochloride, retinol, riboflavin, selenium, thiamine, vitamin b12 nos, vitamin d nos, vitamin e nos, vitamin k nos, zinc (CENTRUM MEN 50+), all taken for an unspecified indication, start and stop date were not reported. The patient experienced pericarditis leading to pericardial effusion on 05Mar2021 20:30. AE treatment included Pericardiocentesis. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The serious criteria for the event was hospitalization, medically significant, life threatening. The patient was hospitalized for 4 days. The patient received bnt162b2, dose 2 Intramuscularly, administered in arm right on 23Mar2021 07:00 AM (Lot Number: EP6955) as single dose for COVID-19 immunisation. Covid tested post vaccination included Nasal Swab Covid19 PCR on 07Mar2021: Negative. The outcome of the event was not recovered.
Severe joint pain, low back pain, migraine, dry cough,shivers, sweat,nausea, vomiting, incresed heart rate( 111-126) Dry mouth, lost appetite, weakness.
Neck stiffness, Headache, Extreme sweating, chest pain, diff. Breathing, and feeling faint.